Health-care companies were flat after strong earnings from one major drug-store chain. CVS Health surged after the pharmacy firm posted quarterly earnings far above the average analyst target, and ...

Leerink analyst Michael Cherny upgraded CVS Health (CVS) to Outperform from Market Perform with a price target of $75, up from $55. The firm ...

CVS CEO David Joyner just finished his first full quarter at the helm. He spoke with Yahoo Finance about the conservative ...

Just as Andrew Witty of UnitedHealth Group did in a call with investors last month, CVS Health’s CEO David Joyner defended ...

However, the healthcare giant beat Wall Street expectations in earnings and revenue in the fourth quarter, sending CVS stock ...

CVS Health CVS turned in solid fourth-quarter results, and its 2025 guidance for 6%-11% adjusted EPS growth without any share ...

Cantor Fitzgerald upgraded CVS Health (CVS) to Overweight from Neutral.Maximize Your Portfolio with Data Driven Insights:Leverage the power of ...

CVS’s stock soared toward after its quarterly profit beat expectations by the widest margin in more than four years.

CVS Health (NYSE: CVS) is a big name in healthcare, and it has generally been seen as a good way to invest in the industry. In addition to its pharmacy retail operations, the company has a ...

logo will not comply with upcoming new requirements ... leading many municipalities and brands to no longer use it. “Ensuring accessibility is about equity and inclusion,” Gauvin said.

Because my dad is no longer here.” “He’s not coming home,” added Jayda. Their father worked as a security guard at CVS on Main Street, where neighbors say crime is a major issue.